string(250) "/component/content/article/5033-with-the-rise-of-precision-medicine-targeted-drugs-and-gene-therapies-lack-of-diversity-in-clinical-trials-can-make-it-more-challenging-to-get-a-complete-picture-of-a-drug-s-safety-efficacy-profile?Itemid=101&catid=171"
English
string(250) "/component/content/article/5033-with-the-rise-of-precision-medicine-targeted-drugs-and-gene-therapies-lack-of-diversity-in-clinical-trials-can-make-it-more-challenging-to-get-a-complete-picture-of-a-drug-s-safety-efficacy-profile?Itemid=101&catid=171"
English
string(250) "/component/content/article/5033-with-the-rise-of-precision-medicine-targeted-drugs-and-gene-therapies-lack-of-diversity-in-clinical-trials-can-make-it-more-challenging-to-get-a-complete-picture-of-a-drug-s-safety-efficacy-profile?Itemid=101&catid=171"
English
With the rise of precision medicine, targeted drugs and gene therapies, lack of diversity in clinical trials can make it more challenging to get a complete picture of a drug’s safety-efficacy profile.